Browse studies

Find your next paid study

70 recruiting studies matching your filters

Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

The purpose of this registry is to compile characteristics of world-wide outcomes for the use of Boston Scientific's commercially available Vercise DBS System …

Parkinson's Disease

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Boston Scientific CorporationNCT02071134

Biofluid Research on Age-Related or Inherited Neurodegeneration (BRAIN)

The aim of this study is to contribute to and continue to sustain a repository of blood samples, nucleic acid (DNA and/or RNA) samples, family history informat…

Frontotemporal Degeneration (FTD)ALS (Amyotrophic Lateral Sclerosis)Primary Progressive Aphasia (PPA)+12 more

Estimated

~$10 – $750

Actual pay is set by the research site.

University of PennsylvaniaNCT07798700

Phase 1

PET Imaging Evaluation of [11C]SY08

The overall goal of the proposed research is to evaluate the use of \[11C\]SY08 as a PET radiotracer for aggregated alpha synuclein (αS) in individuals with Pa…

Parkinson's DiseaseMultiple System AtrophyDementia With Lewy Bodies+1 more

Estimated

~$500 – $7,500

Actual pay is set by the research site.

Massachusetts General HospitalNCT06098612

Observational

Moving Yourself in Space and Time Identifying Spatial and Temporal Components of Complex Rhythmic Movement Training for People With Parkinson's Disease and Cognitive Impairment

This study is being done to answer the question: Do people with Parkinson's benefit from a new stepping therapy, and how do people with Parkinson's best learn …

Parkinson's Disease (PD)Alzheimer's Disease (AD) and Related DisordersOlder Adults (60 - 85 Years Old)

Estimated

~$10 – $750

Actual pay is set by the research site.

Emory UniversityNCT07697664

Observational

Neurovascular Coupling, Clinical Outcomes, and NAD Supplementation in Parkinson's Disease

The goal of this clinical trial is to learn whether Nicotinamide Riboside, a form of Vitamin B3 also known as NR, can improve blood vessel health in the brain,…

Parkinson's Disease

Estimated

~$10 – $750

Actual pay is set by the research site.

University of OklahomaNCT07703137

Observational

Blood Flow Restriction for Optimizing Balance in Parkinson's Disease

This study is being done to understand how reducing blood flow (BRT) during balance-challenging strengthening exercises (instability resistance training, or IR…

Parkinson's Disease and Parkinsonism

Estimated

~$10 – $750

Actual pay is set by the research site.

The University of Texas Health Science Center at San AntonioNCT06508801

Phase 2

A Comparative Performance Study Between High and Standard Resolution Positron Emission Tomography (PET) Camera Using [18F]AV-133 in Prodromal Parkinson's Disease [Dual PET AV133 in Prodromal PD]

This study is a single-center, longitudinal study and will be conducted at the Institute for Neurodegenerative (INDD) Site in New Haven, CT. This study aims to…

Prodromal Parkinson's Disease

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Michael J. Fox Foundation for Parkinson's ResearchNCT07809438

Phase 2

An Open-label Clinical Trial Investigating the Long-term Safety of Buntanetap in Treating Participants With Parkinson's Disease

This study will examine the long-term safety of buntanetap in participants with PD. This will be a 36-month open-label safety study. This study will be conduct…

Parkinson's Disease (PD)Deep Brain Stimulation

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Annovis Bio Inc.NCT07284784

Phase 2

Examining Ketamine Effects on Depression, Neuroplasticity, and Inflammation in Veterans With Parkinson's Disease

Parkinson's disease (PD) is a devastating illness that has a growing impact on Veterans. One of the most disabling symptoms is depression, which is common in P…

Parkinson's Disease

Estimated

~$75 – $1,800

Actual pay is set by the research site.

VA Office of Research and DevelopmentNCT06231563

Phase 2

Multicenter, Randomized, Double Blind, Placebo-Controlled Phase 2a Study, to Evaluate Safety, Tolerability and Pharmacokinetics of Resveratrol (JOTROLTM) in Parkinson's Disease

This is an exploratory phase 2a study to investigate two doses of resveratrol (JotrolTM) vs placebo in individuals diagnosed with Parkinson's Disease (PD). Par…

Parkinson's Disease

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Georgetown UniversityNCT07592767

Phase 2

Efficacy and Safety of Tenapanor in Synucleinopathy-Related Constipation

Investigation of tenapanor as a potential treatment for synucleinopathy-associated constipation

SynucleinopathyParkinson's Disease

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Cedar Valley Digestive Health CenterNCT06460038

Phase 1

A Randomized, Placebo-Controlled, Single Ascending Dose (SAD) Study to Assess the Safety, Tolerability, and Pharmacokinetics of SER-252 in Patients With Parkinson's Disease and Motor Fluctuations

This is a randomized, placebo-controlled, single ascending dose (SAD) study of SER-252 in participants with Parkinson's Disease (PD) and motor fluctuations.

PARKINSON DISEASE (Disorder)Advanced Parkinson's Disease

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Serina TherapeuticsNCT07422675